Sharon Bio-Medicine is currently trading at Rs. 364.05, up by 2.35 points or 0.65% from its previous closing of Rs. 361.70 on the BSE.
The scrip opened at Rs. 365.00 and has touched a high and low of Rs. 366.80 and Rs. 363.00 respectively. So far 13871 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 373.00 on 12-Mar-2012 and a 52 week low of Rs. 154.00 on 08-Apr-2011.
Last one week high and low of the scrip stood at Rs. 366.80 and Rs. 356.00 respectively. The current market cap of the company is Rs. 385.38 crore.
The promoters holding in the company stood at 60.74% while Institutions and Non-Institutions held 0.23% and 39.03% respectively.
Sharon Bio-Medicine’s Chiral active pharma ingredients (API) project has received a subsidy/financial assistance of Rs 6.90 crore from the Ministry of Science & Technology, New Delhi, Government of India.
Earlier, Sharon Bio-Medicine had placed a proposal to technical advisory committee through Technology Development & Demonstration Programme (TDDP) for development of Chiral Technology for Chiral API developments which the company has partially developed in its Research & Development Centre in Navi Mumbai and would like to commercialize in future once the Chiral Technology of API is fully developed.
The Chiral API technology was under active consideration with Technological Promotion Development and Utilizations Programme (TPDUP) which falls under technical advisory committee (TAC) of Department of Scientific and Industrial Research, (DSIR) Ministry of Science & Technology, New Delhi.
Further, Chiral API technology will not only reduce cost of the API manufactured by Sharon but will also be environmental friendly with less of the effluents coming out from the API manufactured products.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1213.90 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 948.70 |
View more.. |